DOKTER INES SAMYN, MEDISCHE ONCOLOGIE
0821.228.328 · rovalta.com · 27/09/2026
DOKTER INES SAMYN, MEDISCHE ONCOLOGIE
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBODOKTER INES SAMYN, MEDISCHE ONCOLOGIE is a Private limited company incorporated in 2009. Its registered office is in Kortrijk.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0821.228.328
- Incorporation
- 02/12/2009
- Legal form
- Private limited company
- Registered office
- Roodhuisweg(Bel) 46
8510 Kortrijk · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 16 filingsTrend over 15 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 205,9 k € | -2.9% | 212,1 k € | +11.2% | 190,7 k € | +11.0% | 171,8 k € | -9.9% | 190,6 k € |
| EBITDA | 204,4 k € | -2.9% | 210,5 k € | +11.2% | 189,3 k € | +11.1% | 170,4 k € | -9.9% | 189,1 k € |
| Operating result | 204,4 k € | -2.9% | 210,5 k € | +11.2% | 189,3 k € | +11.1% | 170,4 k € | -7.1% | 183,3 k € |
| Net result | 136,8 k € | +0.4% | 136,3 k € | +9.1% | 124,9 k € | +15.1% | 108,5 k € | -9.9% | 120,4 k € |
| Balance sheet | |||||||||
| Equity | 1,3 M € | +11.7% | 1,2 M € | +13.2% | 1 M € | +13.8% | 900 k € | -4.2% | 939,6 k € |
| Total assets | 1,6 M € | +9.4% | 1,5 M € | +10.7% | 1,3 M € | +9.9% | 1,2 M € | -3.0% | 1,2 M € |
| Cash | 215,4 k € | -80.3% | 1,1 M € | +15.7% | 945,5 k € | +15.0% | 822 k € | -31.0% | 1,2 M € |
| Debts | 281,6 k € | -3.0% | 290,2 k € | +0.7% | 288,3 k € | -5.2% | 304,1 k € | +0.8% | 301,7 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20241 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 22/08/2025 | 04/07/2024 | 29/08/2023 | 26/08/2022 | 30/08/2021 | 24/07/2020 |
| General meeting | 17/05/2025 | 18/05/2024 | 20/05/2023 | 21/05/2022 | 15/05/2021 | 16/05/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 16 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 17/05/2025 | 22/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 18/05/2024 | 04/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 20/05/2023 | 29/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 21/05/2022 | 26/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 15/05/2021 | 30/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 16/05/2020 | 24/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 18/05/2019 | 31/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 19/05/2018 | 30/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 20/05/2017 | 28/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 21/05/2016 | 19/08/2016 | Dutch | |
| Abridged modelCorrection | 31/12/2014 | 29/06/2015 | 30/09/2015 | Dutch | |
| Abridged model | 31/12/2014 | 29/06/2015 | 26/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/06/2014 | 29/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 30/06/2013 | 26/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 19/05/2012 | 22/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 30/06/2011 | 23/08/2011 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates29/01/2021STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN
- Capital / shares04/02/2014KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Other19/08/2010DIVERSEN
- Other17/12/2009RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024136,8 k €↑
- 2023Annual accounts 2023136,3 k €↑
- 2022Annual accounts 2022124,9 k €↑
- 2021Annual accounts 2021108,5 k €↓
- 2020Annual accounts 2020120,4 k €↑
- 2019Annual accounts 201999,3 k €↑
- 2018Annual accounts 201888,3 k €↓
- 2017Annual accounts 201791 k €↑
- 2016Annual accounts 201683,7 k €↑
- 2015Annual accounts 201571,2 k €↑
- 2014Annual accounts 201468,8 k €↓
- 2013Annual accounts 201372,6 k €↓
- 2012Annual accounts 201284,4 k €↓
- 2011Annual accounts 201196,8 k €↑
- 2010Annual accounts 201068,8 k €
- 02/12/2009IncorporationPrivate limited company